| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193860 | Annals of Allergy, Asthma & Immunology | 2006 | 5 Pages |
Abstract
A single 4-mg tablet of montelukast had the potential to provide additive clinical benefit in mild to moderate acute asthma in preschool-aged children when administered concomitantly with short-acting β2-agonist bronchodilators as the initial treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Koray MD, Arzu MD, Ipek MD, Tuncer PhD,